Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-10-31T23:11:13.332Z Has data issue: false hasContentIssue false

The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis

Published online by Cambridge University Press:  17 March 2015

Yun Tian
Affiliation:
Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China
Keming Wang
Affiliation:
Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China
Juan Li
Affiliation:
Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China
Jirong Wang
Affiliation:
Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China
Zhaoxia Wang
Affiliation:
Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China
Yingrui Fan
Affiliation:
Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China
Ying Ye
Affiliation:
Emergency Center, Affiliated Hospital of Xuzhou Medical College, Xuzhou, People’s Republic of China
Guozhong Ji
Affiliation:
Institute of Digestive Endoscopy and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China
Yi Li*
Affiliation:
Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, No. 305 East Zhongshan Road, Nanjing 210002, People’s Republic of China
*
*Corresponding author: Email liyi_jlh@163.com
Rights & Permissions [Opens in a new window]

Abstract

Objective

There have been inconsistent results published regarding the relationship between dyslipidaemia and an increased risk of colorectal neoplasia (CRN), including colorectal adenoma (CRA) and colorectal cancer (CRC). We conducted a meta-analysis to explore the relationship between dyslipidaemia and CRN.

Design

We identified studies by performing a literature search using PubMed, EMBASE and the Science Citation Index through October 2013.

Setting

We analysed thirty-three independent studies reporting the association between CRN and at least one of the selected lipid components, including total cholesterol (TC), TAG, HDL-cholesterol (HDL-C) and LDL-cholesterol (LDL-C).

Subjects

CRN cases (n 21 809) were identified.

Results

Overall, people with high levels of serum TAG (risk ratio (RR)=1·08; 95 % CI 1·05, 1·12, P<0·00001) and LDL-C (RR=1·07; 95 % CI 1·00, 1·14, P=0·04) presented an increased prevalence of CRN. Subgroup analyses revealed that high levels of serum TC (RR=1·04; 95 % CI 1·01, 1·09, P=0·02), TAG (RR=1·06; 95 % CI 1·03, 1·10, P=0·0009) and LDL-C (RR=1·11; 95 % CI 1·04, 1·19, P=0·003) increased the risk of CRA but not of CRC. No association between serum HDL-C and risk for CRN (including CRA and CRC) was observed.

Conclusions

Both TAG and LDL-C were significantly associated with an increasing prevalence of CRN. High levels of serum TC, TAG and LDL-C were positively associated with CRA but not with CRC. No significant association was observed between levels of serum HDL-C and CRN.

Type
Review Articles
Copyright
Copyright © The Authors 2015 

Colorectal cancer (CRC) is reported to be the fourth most commonly diagnosed cancer and is the second most common cause of cancer deaths in North America( Reference Jemal, Siegel and Ward 1 ). CRC is believed to arise from colorectal adenoma (CRA) through a sequence from adenoma to adenocarcinoma as a consequence of a limited set of molecular events that largely originate with a relatively benign adenoma that progresses to cancer( Reference Jass 2 ). Accumulated data indicate that metachronous lesions occur at a rate of 20 to 30 % per year in post-polypectomy patients. The propensity to develop CRA identifies a sizeable subgroup of the population at an enhanced risk for subsequent adenoma formation and colorectal carcinoma. This indicates that identifying risk factors associated with CRN is essential for the reduction of colorectal carcinoma.

The positive association between obesity and CRA prevalence demonstrates an underlying dose–response relationship according to BMI( Reference Ben, An and Jiang 3 ). Timely screening of obese patients for CRA is thus recommended. Dyslipidaemia is an important component of metabolic syndrome and is demonstrated to contribute to colorectal tumorigenesis through insulin resistance, oxidative stress and inflammatory pathways( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 ). Alteration of serum lipids (high TAG and low HDL-cholesterol (HDL-C)) has been linked to an increased risk of CRA( Reference Giovannucci 5 , Reference Kim, Lim and Kim 6 ) and several types of malignancy including CRC( Reference Jinjuvadia, Lohia and Jinjuvadia 7 ). A recent large case–control study indicated that a high level of serum TAG was significantly associated with a larger number of adenomas( Reference Otani, Iwasaki and Ikeda 8 ). Although several studies have explored the dyslipidaemia component, e.g. lipid and lipoprotein concentrations individually in relation to CRN risk, there is still inconsistency for this issue. More importantly, the association between components of serum lipids and CRN risk is largely unknown.

An increased understanding between the development of CRN and dyslipidaemia can clarify the mechanistic steps linking components of serum lipids and CRN and may be useful in determining the benefits of early CRN screening. Unfortunately, data on the relationship of serum lipid levels with CRA/CRC are contradictory. Some studies have established a positive association between serum total cholesterol (TC) level and CRN. If this theory were correct, it may contribute to an excess in mortality in individuals with dyslipidaemia compared with those without the disorder. However, other studies showed no significant association between CRN and serum lipids( Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 ). Because the association between dyslipidaemia and CRN formation has not yet been systematically assessed, we conducted a systematic review and meta-analysis of all available studies evaluating this issue to investigate the association between components of serum lipids and CRN risk.

Materials and methods

The current review and meta-analysis follows the recommendations of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement( Reference Moher, Liberati and Tetzlaff 11 ).

Search strategy

For the present analysis, a systematic literature search through October 2013 was performed in PubMed, EMBASE and the Science Citation Index to identify relevant studies. Studies investigating the relationship between serum lipids and CRN (including CRA and CRC) were carried out by searching for articles written in English. The search term comprised the following keywords: ‘serum lipids’, ‘triglycerides, TG’, ‘total cholesterol, TC’, ‘high-density lipoprotein-cholesterol, HDL-C, or ‘low-density lipoprotein-cholesterol, LDL-C’ combined with ‘colorectal cancer, CRC’ ‘colorectal adenoma, CRA’ or ‘colorectal neoplasm, CRN’ (see online supplementary material, Supplemental Table 1 for the search strategy in PubMed). All references of the selected articles were checked, including manual searches. Additionally, to find any additional published studies, we interrogated references of all the articles. The titles and abstracts were scanned to exclude any clearly irrelevant studies. The full texts of the remaining articles were read to determine whether they contained information on the topic of interest. All searches were conducted independently by two authors (Y.T. and Y.L.). The results were then compared; any questions or discrepancies were resolved by iteration and consensus.

Study selection

Only publications that fulfilled all of the following criteria were selected for the meta-analysis: (i) the study subjects were adults (older than 18 years); (ii) publication with a case–control, cross sectional, nested case–control or cohort study design; (iii) CRN incidence as the outcome of interest; (iv) reported an estimate of the association of CRN (defined as colorectal cancer or adenoma or both) in individuals with at least one of the selected lipid components (TC, TAG, HDL-C and LDL-cholesterol (LDL-C)); and (v) reported risk ratio (RR; or OR estimates in case–control studies) or hazard ratios (HR) with estimates of their corresponding 95 % CI (or sufficient data to evaluate the above effects).

Data extraction

Information extracted from the extensive review of each publication included: (i) publication data (first author’s name, year of publication and country of the population studied); (ii) type of study design; (iii) study participants’ age range; (iv) sample size (cases and controls or cohort size); (v) type of lesion; (vi) risk estimates with their corresponding CI; (viii) method used to confirm the presence or absence of CRN; and (ix) colonoscopy examination at the time of diagnosis. OR from case–control studies were considered as an estimate of RR( Reference Hogue, Gaylor and Schulz 12 ). If a study provided several risk estimates, the most completely adjusted estimate was extracted and used in the meta-analysis. The information from each study was extracted by two independent researchers (Y.T. and Y.L.), with disagreements resolved with a majority vote by all authors.

Statistical analysis

All analyses, including publication bias, were performed using the computer program Review Manage version 5·1 (Oxford, UK). Study-specific risk estimates were extracted from each study and log risk estimates were weighted by the inverse of their variances to obtain a pooled risk estimate. The heterogeneity of all publications was evaluated with the Cochran Q test and I 2 statistic( Reference Higgins and Thompson 13 ). An I 2 value of <30 %, 30–50 % and >50 % was considered as little or no heterogeneity, moderate heterogeneity and severe heterogeneity, respectively. For the Q statistic, a P value of <0·1 was considered to have significant heterogeneity. Summaries of RR estimates were evaluated using both fixed-effects and random-effects methods. Random effects are used when heterogeneity is present. Initial analysis, including all studies, was performed to look for an association between serum lipids and CRN. Subgroup analyses were also carried out to estimate the components of serum lipids and the risk of CRC and CRA. For meta-analysis results, the P value of <0·05 indicated statistical significance. A funnel plot for potential publication bias analysis was conducted using the statistical software package Stata 11·0 with Begg( Reference Begg and Mazumdar 14 ) and Egger tests( Reference Egger, Davey Smith and Schneider 15 ).

Results

Study characteristics

Two hundred and eighty-five publications relevant to the words searched were retrieved using the methodology and the search terms described above. Of these, eighty-two duplicated publications were excluded. The remaining 203 studies were selected for further evaluation based on information from abstracts and titles. After screening abstracts and titles, forty-seven studies were considered to be relevant to our study subject. Fourteen articles were excluded as they did not investigate the association of serum lipids with risk of CRN. In total, thirty-three records that met the detailed inclusion criteria were included in the present meta-analysis( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Kim, Lim and Kim 6 , Reference Otani, Iwasaki and Ikeda 8 Reference Yang, Rampal and Sung 10 , Reference Ahmed, Schmitz and Anderson 16 Reference Yamada, Araki and Tamura 43 ). All studies reported on at least one of the serum lipid components (TC, TAG, HDL-C and LDL-C) and the risk of CRN. Details of these studies are described in Tables 1 and 2.

Table 1 Studies contributing to the analysis of serum lipids and colorectal cancer

RR, risk ratio; HDL-C, HDL-cholesterol; TC, total cholesterol; LDL-C, LDL-cholesterol.

Table 2 Studies contributing to the analysis of serum lipids and colorectal adenoma

RR, risk ratio; TC, total cholesterol; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol.

Overall analyses on the association of serum lipids and colorectal neoplasm

The association between serum TC and risk of CRN was analysed first. The sixteen studies on TC (four cohort, five cross-sectional and seven case–control studies) were published between 1990 and 2013 (Tables 1 and 2) and involved a total of 21809 CRN cases( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Bayerdorffer, Mannes and Richter 19 Reference Chung, Han and Park 22 , Reference Iso, Ikeda and Inoue 25 , Reference Kono, Ikeda and Yanai 28 , Reference Kono, Imanishi and Shinchi 29 , Reference Stocks, Lukanova and Bjorge 34 , Reference Tabuchi, Kitayama and Nagawa 36 , Reference Trichopoulou, Tzonou and Hsieh 38 , Reference Tsilidis, Brancati and Pollak 39 , Reference Wulaningsih, Garmo and Holmberg 42 , Reference Yamada, Araki and Tamura 43 ). Three studies were conducted in the USA( Reference Bird, Ingles and Frankl 20 , Reference Trichopoulou, Tzonou and Hsieh 38 , Reference Tsilidis, Brancati and Pollak 39 ), one in Sweden( Reference Wulaningsih, Garmo and Holmberg 42 ), three in Korea( Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Chung, Han and Park 22 ), five in Japan( Reference Iso, Ikeda and Inoue 25 , Reference Kono, Ikeda and Yanai 28 , Reference Kono, Imanishi and Shinchi 29 , Reference Tabuchi, Kitayama and Nagawa 36 , Reference Yamada, Araki and Tamura 43 ), one in Finland( Reference Bowers, Albanes and Limburg 21 ), one in Germany( Reference Bayerdorffer, Mannes and Richter 19 ) and two in European countries( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Inoue, Noda and Kurahashi 24 ) (Tables 1 and 2). A random-effects model was considered for a summary RR as there was evidence of heterogeneity for the included sixteen studies (Q=45·28, P value for heterogeneity =0·00001, I 2=65 %). The overall RR for CRN (adenoma or colon cancer) associated with serum TC was 1·00 (95 % CI 0·93, 1·08, P=0·93; Fig. 1(a)), while the funnel plot for potential publication bias was also analysed (Fig. 1(b)). Our result indicated that there was no statistical evidence of publication bias (Egger’s P=0·638, Begg’s P=0·837).

Fig. 1 Association between TC and CRN (adenoma and cancer combined): (a) forest plot; (b) funnel plot. In (a), the study-specific RR and 95 % CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond presents the pooled RR risk and its width represents the pooled 95 % CI. In (b), Begg’s funnel plot with pseudo 95 % CI is presented (TC, total cholesterol; CRN, colorectal neoplasm; RR, risk ratio; IV, fixed-effects model; HR, hazard ratio)

There were twenty-nine studies reported on TAG (twelve cohort studies, four cross-sectional and thirteen case–control studies) published between 1990 and 2013 and involved a total of 31546 CRN cases (Tables 1 and 2)( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Kim, Lim and Kim 6 , Reference Otani, Iwasaki and Ikeda 8 Reference Yang, Rampal and Sung 10 , Reference Ahmed, Schmitz and Anderson 16 Reference Ashbeck, Jacobs and Martinez 18 , Reference Bird, Ingles and Frankl 20 , Reference Chung, Han and Park 22 Reference Inoue, Noda and Kurahashi 24 , Reference Kaneko, Sato and An 26 Reference Saydah, Platz and Rifai 32 ). Nine studies were conducted in the USA( Reference Ahmed, Schmitz and Anderson 16 , Reference Ashbeck, Jacobs and Martinez 18 , Reference Bird, Ingles and Frankl 20 , Reference Saydah, Platz and Rifai 32 , Reference Sturmer, Buring and Lee 35 , Reference Trevisan, Liu and Muti 37 Reference Tsushima, Nomura and Lee 40 ), one in Sweden( Reference Wulaningsih, Garmo and Holmberg 42 ), five in Korea( Reference Kim, Lim and Kim 6 , Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Chung, Han and Park 22 , Reference Kim, Shin and Hong 27 ), two in China( Reference Hu, Chen and Lin 23 , Reference Liu, Hsu and Li 30 ), eight in Japan( Reference Otani, Iwasaki and Ikeda 8 , Reference Inoue, Noda and Kurahashi 24 , Reference Kaneko, Sato and An 26 , Reference Kono, Ikeda and Yanai 28 , Reference Kono, Imanishi and Shinchi 29 , Reference Morita, Tabata and Mineshita 31 , Reference Tabuchi, Kitayama and Nagawa 36 , Reference Yamada, Araki and Tamura 43 ), one in Austria( Reference Ulmer, Borena and Rapp 41 ) and three in European countries( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Aleksandrova, Boeing and Jenab 17 , Reference Stocks, Lukanova and Bjorge 34 ) (Tables 1 and 2). Pooled analysis showed a significant association between serum TAG and CRN (n 29 studies; summary RR=1·08; 95 % CI 1·05, 1·12, P<0·00001; Fig. 2(a)). A random-effects model was considered for a summary RR because of the significant heterogeneity of the included twenty-nine studies (Q=110·44, P value for heterogeneity<0·00001, I 2=68 %). The funnel plot for potential publication bias was also implemented (Fig. 2(b)); the results of the statistical analysis showed a potential publication bias (Egger’s P=0·006, Begg’s P=0·225).

Fig. 2 Association between TAG and CRN (adenoma and cancer combined): (a) forest plot; (b) funnel plot. In (a), the study-specific RR and 95 % CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond presents the pooled RR risk and its width represents the pooled 95 % CI. In (b), Begg’s funnel plot with pseudo 95 % CI is presented (CRN, colorectal neoplasm; RR, risk ratio; IV, fixed-effects model; HR, hazard ratio)

Next, we performed an analysis to evaluate the association between serum LDL-C and risk of CRN. There were a total of eight studies carried out on LDL-C (three cohort studies, three cross-sectional and two case–control studies) published between 1993 and 2013 which included 12 473 CRN cases (Tables 1 and 2)( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Bayerdorffer, Mannes and Richter 19 , Reference Kaneko, Sato and An 26 , Reference Kono, Imanishi and Shinchi 29 , Reference Schoen, Tangen and Kuller 33 , Reference Wulaningsih, Garmo and Holmberg 42 ). One study was conducted in the USA( Reference Schoen, Tangen and Kuller 33 ), one in Sweden( Reference Wulaningsih, Garmo and Holmberg 42 ), one in Germany( Reference Bayerdorffer, Mannes and Richter 19 ), two in Korea( Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 ), two in Japan( Reference Kaneko, Sato and An 26 , Reference Kono, Imanishi and Shinchi 29 ) and one in European countries( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 ) (Tables 1 and 2). Data provided evidence that LDL-C is an increased risk factor of CRN development (summary RR=1·07; 95 % CI 1·00, 1·14, P=0·04; Fig. 3(a)). A random-effects model was considered for summary RR due to the existence of heterogeneity of the included eight studies (Q=79·32, P value for heterogeneity <0·00001, I 2=90 %), while the funnel plot for potential publication bias was also conducted (Fig. 3(b)). Results of the statistical analysis showed no significant publication bias (Egger’s P=0·573, Begg’s P=0·835).

Fig. 3 Association between LDL-C and CRN (adenoma and cancer combined): (a) forest plot; (b) funnel plot. In (a), the study-specific RR and 95 % CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond presents the pooled RR risk and its width represents the pooled 95 % CI. In (b), Begg’s funnel plot with pseudo 95 % CI is presented (LDL-C, LDL-cholesterol; CRN, colorectal neoplasm; RR, risk ratio; IV, fixed-effects model; HR, hazard ratio)

Finally, we performed analysis of studies to evaluate the association between HDL-C and CRN. The included twenty-three studies on HDL-C (ten cohort studies, four cross-sectional and nine case–control studies) were published between 1990 and 2013 (Tables 1 and 2) and involved a total of 21426 CRN cases( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Kim, Lim and Kim 6 , Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Ahmed, Schmitz and Anderson 16 Reference Bowers, Albanes and Limburg 21 , Reference Hu, Chen and Lin 23 , Reference Inoue, Noda and Kurahashi 24 , Reference Kaneko, Sato and An 26 Reference Morita, Tabata and Mineshita 31 , Reference Schoen, Tangen and Kuller 33 , Reference Trevisan, Liu and Muti 37 Reference Tsilidis, Brancati and Pollak 39 , Reference Wulaningsih, Garmo and Holmberg 42 ). Seven studies were conducted in the USA( Reference Ahmed, Schmitz and Anderson 16 , Reference Ashbeck, Jacobs and Martinez 18 , Reference Bird, Ingles and Frankl 20 , Reference Schoen, Tangen and Kuller 33 , Reference Trevisan, Liu and Muti 37 Reference Tsilidis, Brancati and Pollak 39 ), one in Sweden( Reference Wulaningsih, Garmo and Holmberg 42 ), one in Germany( Reference Bayerdorffer, Mannes and Richter 19 ), two in China( Reference Hu, Chen and Lin 23 , Reference Liu, Hsu and Li 30 ), four in Korea( Reference Kim, Lim and Kim 6 , Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Kim, Shin and Hong 27 ), five in Japan( Reference Inoue, Noda and Kurahashi 24 , Reference Kaneko, Sato and An 26 , Reference Kono, Ikeda and Yanai 28 , Reference Kono, Imanishi and Shinchi 29 , Reference Morita, Tabata and Mineshita 31 ), one in Finland( Reference Bowers, Albanes and Limburg 21 ) and two in European countries( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Aleksandrova, Boeing and Jenab 17 ) (Tables 1 and 2). A random-effects model was considered for a summary RR as there was significant heterogeneity of the included twenty-three studies (Q=63·10, P value for heterogeneity=0·0001, I 2=57 %). Analysis of the twenty-three studies indicated that HDL-C was not significantly associated with CRN (RR=1·03; 95 % CI 0·98, 1·07, P=0·25; Fig. 4(a)), while the funnel plot for potential publication bias was also analysed (Fig. 4(b)). Our result indicated that there was no statistical evidence of publication bias (Egger’s P=0·983, Begg’s P=0·252).

Fig. 4 Association between HDL-C and CRN (adenoma and cancer combined): (a) forest plot; (b) funnel plot. In (a), the study-specific RR and 95 % CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond presents the pooled RR risk and its width represents the pooled 95 % CI. In (b), Begg’s funnel plot with pseudo 95 % CI is presented (HDL-C, HDL- cholesterol; CRN, colorectal neoplasm; RR, risk ratio; IV, fixed-effects model; HR, hazard ratio)

Overall analyses on the association of serum lipids and colorectal cancer

Eight publications in the present meta-analysis on TC (four cohort and four case–control studies) and risk of CRC were published between 1992 and 2012 and involved a total of 10 979 CRC cases (Table 1)( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Bowers, Albanes and Limburg 21 , Reference Chung, Han and Park 22 , Reference Iso, Ikeda and Inoue 25 , Reference Stocks, Lukanova and Bjorge 34 , Reference Trichopoulou, Tzonou and Hsieh 38 , Reference Wulaningsih, Garmo and Holmberg 42 , Reference Yamada, Araki and Tamura 43 ). One study was conducted in the USA( Reference Trichopoulou, Tzonou and Hsieh 38 ), one in Sweden( Reference Wulaningsih, Garmo and Holmberg 42 ), one in Korea( Reference Chung, Han and Park 22 ), two in Japan( Reference Iso, Ikeda and Inoue 25 , Reference Yamada, Araki and Tamura 43 ), one in Finland( Reference Bowers, Albanes and Limburg 21 ) and two in European countries( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Stocks, Lukanova and Bjorge 34 ) (Table 1). Pooled data did not support the association between TC and CRC (RR=0·95; 95 % CI 0·85, 1·06, P=0·38). There was a statistically significant heterogeneity among studies (Q=40·30, P value for heterogeneity <0·00001, I 2=80 %; Table 3).

Table 3 Summary risk estimates of the association between serum lipids and colorectal cancer and adenoma risk

RR, risk ratio; TC, total cholesterol; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol.

The association between serum TAG and risk of CRC was analysed. Fourteen studies on TAG (eight cohort and six case–control studies) and risk of CRC were published between 1992 and 2012 and involved a total of 13 785 CRC cases (Table 1)( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Ahmed, Schmitz and Anderson 16 , Reference Aleksandrova, Boeing and Jenab 17 , Reference Chung, Han and Park 22 , Reference Inoue, Noda and Kurahashi 24 , Reference Saydah, Platz and Rifai 32 , Reference Stocks, Lukanova and Bjorge 34 , Reference Sturmer, Buring and Lee 35 , Reference Trevisan, Liu and Muti 37 , Reference Trichopoulou, Tzonou and Hsieh 38 , Reference Tsushima, Nomura and Lee 40 Reference Yamada, Araki and Tamura 43 ). Six studies were conducted in the USA( Reference Ahmed, Schmitz and Anderson 16 , Reference Saydah, Platz and Rifai 32 , Reference Sturmer, Buring and Lee 35 , Reference Trevisan, Liu and Muti 37 , Reference Trichopoulou, Tzonou and Hsieh 38 , Reference Tsushima, Nomura and Lee 40 ), one in Sweden( Reference Wulaningsih, Garmo and Holmberg 42 ), one in Korea( Reference Chung, Han and Park 22 ), one in Austria( Reference Ulmer, Borena and Rapp 41 ) two in Japan( Reference Inoue, Noda and Kurahashi 24 , Reference Yamada, Araki and Tamura 43 ) and three in European countries( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Aleksandrova, Boeing and Jenab 17 , Reference Stocks, Lukanova and Bjorge 34 ) (Table 1). The association of serum TAG with CRC risk was not observed (RR=1·07; 95 % CI 0·99, 1·15; P=0·10). A random-effects model was constructed as there was statistically significant heterogeneity among studies (Q=31·81, P value for heterogeneity=0·01, I 2=50 %; Table 3).

The association between serum HDL-C and risk of CRC was then analysed in our study. Nine studies on HDL-C (six cohort and three case–control studies) and risk of CRC were published between 1992 and 2012 and involved a total of 7328 CRC cases (Table 1)( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Ahmed, Schmitz and Anderson 16 , Reference Aleksandrova, Boeing and Jenab 17 , Reference Bowers, Albanes and Limburg 21 , Reference Inoue, Noda and Kurahashi 24 , Reference Schoen, Tangen and Kuller 33 , Reference Trevisan, Liu and Muti 37 , Reference Trichopoulou, Tzonou and Hsieh 38 , Reference Wulaningsih, Garmo and Holmberg 42 ). Four studies were conducted in the USA( Reference Ahmed, Schmitz and Anderson 16 , Reference Schoen, Tangen and Kuller 33 , Reference Trevisan, Liu and Muti 37 , Reference Trichopoulou, Tzonou and Hsieh 38 ), one in Sweden( Reference Wulaningsih, Garmo and Holmberg 42 ), one in Japan( Reference Inoue, Noda and Kurahashi 24 ), one in Finland( Reference Bowers, Albanes and Limburg 21 ) and two in European countries( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Aleksandrova, Boeing and Jenab 17 ) (Table 1). The pooled RR of serum HDL-C for CRC was 0·97 (95 % CI 0·80, 1·18, P=0·77), suggesting no significant relevance. Statistically significant heterogeneity existed among studies (Q=33·01, P value for heterogeneity=0·0001, I 2=73 %; Table 3).

There were three studies regarding LDL-C (two cohort and one case–control study) and risk of CRC that were published between 1990 and 2013 and involved a total of 5322 CRC cases (Table 1)( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 , Reference Schoen, Tangen and Kuller 33 , Reference Wulaningsih, Garmo and Holmberg 42 ). One study was conducted in the USA( Reference Schoen, Tangen and Kuller 33 ), one in Sweden( Reference Wulaningsih, Garmo and Holmberg 42 ) and one in European countries( Reference van Duijnhoven, Bueno-De-Mesquita and Calligaro 4 ) (Table 1). The association between serum LDL-C and CRC risk was not observed (RR=0·88; 95 % CI 0·77, 1·01, P=0·07). A fixed-effects model was used as there was no statistically significant heterogeneity among studies (Q=5·34, P value for heterogeneity=0·07, I 2=63 %; Table 3).

Overall analyses on the association of serum lipids and colorectal adenoma

Nine studies reporting associations between TC (five cross-sectional and four case–control studies) and risk of CRA were published between 1990 and 2013 and involved a total of 10 935 CRA cases (Table 2)( Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Bayerdorffer, Mannes and Richter 19 , Reference Bird, Ingles and Frankl 20 , Reference Chung, Han and Park 22 , Reference Kono, Ikeda and Yanai 28 , Reference Kono, Imanishi and Shinchi 29 , Reference Tabuchi, Kitayama and Nagawa 36 , Reference Tsilidis, Brancati and Pollak 39 ). Two studies were conducted in the USA( Reference Bird, Ingles and Frankl 20 , Reference Tsilidis, Brancati and Pollak 39 ), one in Germany( Reference Bayerdorffer, Mannes and Richter 19 ), three in Korea( Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Chung, Han and Park 22 ) and three in Japan( Reference Kono, Ikeda and Yanai 28 , Reference Kono, Imanishi and Shinchi 29 , Reference Tabuchi, Kitayama and Nagawa 36 ) (Table 2). The results from nine studies showed that serum TC had a significant association with risk of CRA (RR=1·04; 95 % CI 1·01, 1·09, P=0·02) and there was no significant heterogeneity among these studies (Q=5·26, P value for heterogeneity=0·73, I 2=0 %; Table 3).

We next performed a meta-analysis specifically for TAG and risk of CRA. The sixteen studies on TAG (four cohort studies, four cross-sectional and eight case–control studies) and risk of CRA were published between 1990 and 2013 and involved a total of 17 830 CRA cases (Table 2)( Reference Kim, Lim and Kim 6 , Reference Otani, Iwasaki and Ikeda 8 Reference Yang, Rampal and Sung 10 , Reference Ashbeck, Jacobs and Martinez 18 , Reference Bird, Ingles and Frankl 20 , Reference Chung, Han and Park 22 , Reference Hu, Chen and Lin 23 , Reference Kaneko, Sato and An 26 Reference Morita, Tabata and Mineshita 31 , Reference Tabuchi, Kitayama and Nagawa 36 , Reference Tsilidis, Brancati and Pollak 39 ). Three studies were conducted in the USA( Reference Ashbeck, Jacobs and Martinez 18 , Reference Bird, Ingles and Frankl 20 , Reference Tsilidis, Brancati and Pollak 39 ), five in Korea( Reference Kim, Lim and Kim 6 , Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Chung, Han and Park 22 , Reference Kim, Shin and Hong 27 ), two in China( Reference Hu, Chen and Lin 23 , Reference Liu, Hsu and Li 30 ) and six in Japan( Reference Otani, Iwasaki and Ikeda 8 , Reference Kaneko, Sato and An 26 , Reference Kono, Ikeda and Yanai 28 , Reference Kono, Imanishi and Shinchi 29 , Reference Morita, Tabata and Mineshita 31 , Reference Tabuchi, Kitayama and Nagawa 36 ) (Table 2). The pooled RR for CRA was 1·06 (95 % CI 1·03, 1·10, P=0·0009) which indicated that serum TAG was significantly associated with CRA development. Significant between-study heterogeneity was found in this analysis (Q=62·15, P value for heterogeneity <0·00001, I 2=69 %; Table 3).

There were fourteen studies on HDL-C (four cohort studies, four cross-sectional and six case–control studies) and risk of CRA published between 1990 and 2013 and involved a total of 14 098 CRA cases (Table 2)( Reference Kim, Lim and Kim 6 , Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Ashbeck, Jacobs and Martinez 18 Reference Bird, Ingles and Frankl 20 , Reference Hu, Chen and Lin 23 , Reference Kaneko, Sato and An 26 Reference Morita, Tabata and Mineshita 31 , Reference Tsilidis, Brancati and Pollak 39 ). Three studies were conducted in the USA( Reference Ashbeck, Jacobs and Martinez 18 , Reference Bird, Ingles and Frankl 20 , Reference Tsilidis, Brancati and Pollak 39 ), one in Germany( Reference Bayerdorffer, Mannes and Richter 19 ), two in China( Reference Hu, Chen and Lin 23 , Reference Liu, Hsu and Li 30 ), four in Korea( Reference Kim, Lim and Kim 6 , Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Kim, Shin and Hong 27 ) and four in Japan( Reference Kaneko, Sato and An 26 , Reference Kono, Ikeda and Yanai 28 , Reference Kono, Imanishi and Shinchi 29 , Reference Morita, Tabata and Mineshita 31 ) (Table 2). A pooled analysis of these fourteen studies showed that the RR for CRA with serum HDL-C was 1·03 (95 % CI 0·99, 1·06, P=0·12) with a significant heterogeneity indicated (Q=29·88, P value for heterogeneity=0·03, I 2=43 %; Table 3).

Finally, we performed a meta-analysis specifically for the association between LDL-C and risk of CRA. Five studies on LDL-C (one cohort study, three cross-sectional and one case-control study) and risk of CRA were published between 1990 and 2013 and involved a total of 7151 CRA cases (Table 2)( Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 , Reference Bayerdorffer, Mannes and Richter 19 , Reference Kaneko, Sato and An 26 , Reference Kono, Imanishi and Shinchi 29 ). One study was conducted in Germany( Reference Bayerdorffer, Mannes and Richter 19 ), two in Korea( Reference Park, Joo and Kim 9 , Reference Yang, Rampal and Sung 10 ) and two in Japan( Reference Kaneko, Sato and An 26 , Reference Kono, Imanishi and Shinchi 29 ) (Table 2). Because there was statistical heterogeneity among studies (Q=70·43, P value for heterogeneity<0·00001, I 2=93 %), the random-effects model was applied. The pooled RR for CRA was 1·11 (95 % CI 1·04, 1·19, P=0·003) which presented an increased risk for CRA (Table 3).

Subgroup and sensitivity analyses

The association of lipid components with risk for CRN was performed by subsets within the study design, geographic area, age, gender or the number of cases. Table 4 presents detailed results of subgroup analyses.

Table 4 Results of subgroup analysis of serum lipids and colorectal neoplasm risk

RR, risk ratio; TC, total cholesterol; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol.

We performed a sensitivity analyses to explore the heterogeneity among studies of serum lipids and CRN. By using a stepwise process, we determined that most of the heterogeneity was accounted for in two studies( Reference Bowers, Albanes and Limburg 21 , Reference Trichopoulou, Tzonou and Hsieh 38 ) reporting the association between TC and CRN. After excluding the two studies, there was no study heterogeneity (P=0·15, I 2=27 %) and the RR for CRN was 1·04 (95 % CI 1·01, 1·07). Most of the heterogeneity was accounted for in eight studies( Reference Otani, Iwasaki and Ikeda 8 Reference Yang, Rampal and Sung 10 , Reference Saydah, Platz and Rifai 32 , Reference Stocks, Lukanova and Bjorge 34 , Reference Tabuchi, Kitayama and Nagawa 36 , Reference Wulaningsih, Garmo and Holmberg 42 , Reference Yamada, Araki and Tamura 43 ) reporting the association between TAG and CRN. After excluding these studies, there was no study heterogeneity (P=0·11, I 2=26 %) and the RR for CRN was 1·01 (95 % CI 1·00, 1·01). We found that most of the heterogeneity was accounted for in two studies( Reference Yang, Rampal and Sung 10 , Reference Bayerdorffer, Mannes and Richter 19 ) reporting the association between HDL-C and CRN. After excluding the two studies, there was no study heterogeneity (P=0·14, I 2=38 %) and the RR for CRN was 1·00 (95 % CI 0·99, 1·01). Most of the heterogeneity was accounted for in four studies( Reference Aleksandrova, Boeing and Jenab 17 , Reference Bayerdorffer, Mannes and Richter 19 , Reference Liu, Hsu and Li 30 , Reference Trichopoulou, Tzonou and Hsieh 38 ) reporting the association between LDL-C and CRN. After excluding these studies, there was no study heterogeneity (P=0·16, I 2=23 %) and the RR for CRN was 1·01 (95 % CI 1·00, 1·02).

Discussion

Our data clearly indicated the positive association between serum TAG and LDL-C and the increased risk of CRN. Subgroup analysis indicated that serum TAG was associated with an increased risk of CRA, but not CRC. It remains uncertain whether TAG is the causal factor responsible for increasing the risk of CRA but not for CRC, although several mechanisms have tried to explain the association between increasing TAG levels and CRN risk. Serum TAG plays an important role in insulin-like growth factor-1 levels( Reference Ibrahim and Yee 44 ), a hormone with proliferative and anti-apoptotic effects. It is demonstrated that the insulin/insulin-like growth factor-1 pathway increases the activity of the ras protein occurring in abnormal colonocytes and stimulates the progression of adenomas into cancers through mediating mitogenicity by activation of K-ras( Reference Siddiqui 45 ). Additionally, hypertriacylglycerolaemia also increases pro-inflammatory cytokines, including IL-6 and TNF-α, while decreasing anti-inflammatory cytokines such as IL-10. The increased inflammatory response has been linked to DNA damage and to effects on the growth, apoptosis and proliferation of colorectal tumour cells. Furthermore, high levels of serum TAG may also result in oxidative stress and in the development of reactive oxygen species( Reference Cowey and Hardy 46 ), which could damage DNA and affect carcinogenesis by affecting gene expression, mutation and chromosomal rearrangement( Reference Valko, Izakovic and Mazur 47 ). Serum TAG may also affect colorectal tumorigenesis by mechanisms involving modification of bile acid excretion, circulating hormones and energy supply to neoplastic cells( Reference McKeown-Eyssen 48 ). Experiments with animal models indicated that Apc-deficient mice showed age-dependent hypertriacylglycerolaemia and a number of intestinal polyp formations, which could be suppressed by anti-hyperlipidaemic medicines. This was confirmed by another report that azoxymethane injection in obese rats with hypertriacylglycerolaemia resulted in an increased number of advanced colon aberrant crypt foci, which are putative precursors of colon cancer( Reference Raju and Bird 49 ). In Apc-deficient FAP model mice, because of the reduced activity of the lipoprotein lipase, serum TAG and intestinal polyp formation decreased significantly after systemic administration of a PPAR ligand( Reference Niho, Mutoh and Takahashi 50 ). Although the biological or molecular mechanism is unclear so far, experiments with animal models most likely showed a clear association between TAG and intestinal neoplasms. Further laboratory and epidemiological studies are still necessary to shed light on the association between serum TAG and CRN development.

Our meta-analysis showed no positive association between TC level and the prevalence of CRN or CRC, although a suggestive association was observed in CRA. A prospective study showed a significant association between serum TC and CRC, which also indicated the risk was higher in patients with colon cancer than with rectal cancer( Reference Tornberg, Holm and Carstensen 51 ). The possible association between TC and colorectal tumorigenesis may be at least partly caused by genetic factors, such as an apoE phenotype which affects both cholesterol metabolism and susceptibility to carcinoma( Reference Kervinen, Sodervik and Makela 52 ). However, the pooled results of our study did not provide evidence for the association between TC and CRN. In our study, we found different associations of serum TC with CRA and CRC. Further research including a large number of studies is necessary to clarify this issue.

In our meta-analysis, higher levels of serum LDL-C were significantly associated with an increasing prevalence of CRN, while serum HDL-C levels were not significantly associated with a decreasing prevalence of CRN. Subgroup analysis demonstrated the positive association between serum LDL-C and CRA, although it was not associated with CRC. HDL-C, however, did not associate with either CRA or CRC. Previous studies have demonstrated that lipids and lipoproteins have been associated with neoplastic processes such as inflammation( Reference Esteve, Ricart and Fernandez-Real 53 ), insulin resistance and oxidative stress. Although there are several possible mechanisms whereby serum lipoproteins influence CRC, little is known regarding the mechanisms by which LDL-C and HDL-C participate in colorectal carcinogenesis. Further mechanistic studies are needed to understand the deferent roles of LDL-C and HDL-C in the development of CRA as well as advanced carcinoma.

The other important finding is that none of the components of serum lipids included in the present meta-analysis (TAG, TC, HDL-C and LDL-C) was significantly correlated with the development of CRC, although positive associations between serum TAG, TC and LDL-C and CRA were found. It was previously reported the significant association of LDL-C with low-grade but not with high-grade CRA( Reference Kaneko, Sato and An 26 ), a stronger correlation between high levels of serum TAG and the number of adenomas, and different associations of serum lipids and adenomas according to histological examination( Reference Otani, Iwasaki and Ikeda 8 ). With the accumulated data, it is difficult to interpret the different effects of serum lipids on CRA and CRC because of the limited mechanisms that have demonstrated a clear biological plausibility for differential effects of lipids on the development of adenoma and advanced carcinoma. Because the potential effects of lipid parameters on different stages of colorectal carcinogenesis have not yet been established, this provides a potential chance for further study.

Our meta-analysis of studies with large numbers of incident cases provides high statistical power for estimating the relationship between components of serum lipids and prevalence of CRN. Despite the strength of the meta-analysis, our study also has several limitations. First, several studies we included are observational. Second, a meta-analysis is not able to solve problems with confounding factors because it did not take into account other possible confounding variables such as dietary patterns, family history of colon cancer and alcohol use, which might be associated with the risk of CRN. However, most studies in the meta-analysis adjusted for other known and potential risk factors for CRN development. Third, heterogeneity may be introduced because of methodological and demographic differences among studies, although appropriate well-motivated inclusion criteria were used. Fourth, the RR values of the baseline serum lipids were endorsed by different panels/organizations in the original studies. Finally, the individual studies may adjust for different covariates including diets, which may affect our results. It is reported that several attributes of diet (such as alcohol and high intake of saturated fats) appear to alter levels of individual lipids( Reference Hegsted and Kritchevsky 54 , Reference Rietman, Schwarz and Blokker 55 ). Many of these diets, which determine serum lipid levels, are established risk factors for CRN( Reference Vargas and Thompson 56 , Reference Vrieling and Kampman 57 ). Therefore, dietary factors might be an important confounding factor in our study.

Conclusion

In conclusion, the present systematic review and meta-analysis demonstrated that high levels of serum TAG and LDL-C are positively associated with the prevalence of CRN. In addition, persons with high levels of the serum lipid components TC, TAG and LDL-C have a greater risk of suffering from CRA but not CRC. Neither CRA nor CRC is linked with serum HDL-C levels. Given the rise in the epidemic of dyslipidaemia worldwide, health-care providers should be more vigilant and adhere with colorectal carcinogenesis screening guidelines in subjects with dyslipidaemia, especially those with abnormal serum TAG, TC and LDL-C levels.

Acknowledgements

Sources of funding: This study was supported in part by funding from the National Natural Science Foundation of China (Y.T., grant number 81302110) (Y.L., grant number 81200263). The National Natural Science Foundation of China had no role in the design, analysis or writing of this article. Conflict of interest: The authors have declared no conflicts of interest. Authorship: Y.T., K.W. and J.L. contributed equally to this work. Y.L. and Y.T. conceived and designed the study, and were involved in drafting of the manuscript; K.W. and J.L. were involved in study concept and design; J.W., Z.W. and Y.F. were involved analysis and interpretation of data; Y.Y. was involved in acquisition of data; G.J. and Y.L. were involved critical revision of the manuscript for important intellectual content. Ethics of human subject participation: Ethical approval was not required.

Supplementary material

To view supplementary material for this article, please visit http://dx.doi.org/10.1017/S1368980015000646

Footnotes

The first three authors contributed equally to this work.

References

1. Jemal, A, Siegel, R, Ward, E et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56, 106130.CrossRefGoogle ScholarPubMed
2. Jass, JR (2006) Colorectal cancer: a multipathway disease. Crit Rev Oncog 12, 273287.CrossRefGoogle ScholarPubMed
3. Ben, Q, An, W, Jiang, Y et al. (2012) Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142, 762772.CrossRefGoogle ScholarPubMed
4. van Duijnhoven, FJ, Bueno-De-Mesquita, HB, Calligaro, M et al. (2011) Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 60, 10941102.Google Scholar
5. Giovannucci, E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86, issue 3, s836s842.CrossRefGoogle ScholarPubMed
6. Kim, JH, Lim, YJ, Kim, YH et al. (2007) Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 16, 15431546.CrossRefGoogle ScholarPubMed
7. Jinjuvadia, R, Lohia, P, Jinjuvadia, C et al. (2013) The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol 47, 3344.Google Scholar
8. Otani, T, Iwasaki, M, Ikeda, S et al. (2006) Serum triglycerides and colorectal adenoma in a case–control study among cancer screening examinees (Japan). Cancer Causes Control 17, 12451252.Google Scholar
9. Park, SK, Joo, JS, Kim, DH et al. (2000) Association of serum lipids and glucose with the risk of colorectal adenomatous polyp in men: a case–control study in Korea. J Korean Med Sci 15, 690695.CrossRefGoogle Scholar
10. Yang, MH, Rampal, S, Sung, J et al. (2013) The association of serum lipids with colorectal adenomas. Am J Gastroenterol 108, 833841.Google Scholar
11. Moher, D, Liberati, A, Tetzlaff, J et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6, e1000097.CrossRefGoogle ScholarPubMed
12. Hogue, CJ, Gaylor, DW & Schulz, KF (1983) Estimators of relative risk for case–control studies. Am J Epidemiol 118, 396407.CrossRefGoogle ScholarPubMed
13. Higgins, JP & Thompson, SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21, 15391558.CrossRefGoogle ScholarPubMed
14. Begg, CB & Mazumdar, M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 10881101.CrossRefGoogle Scholar
15. Egger, M, Davey Smith, G, Schneider, M et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629634.CrossRefGoogle ScholarPubMed
16. Ahmed, RL, Schmitz, KH, Anderson, KE et al. (2006) The metabolic syndrome and risk of incident colorectal cancer. Cancer 107, 2836.Google Scholar
17. Aleksandrova, K, Boeing, H, Jenab, M et al. (2011) Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study. Cancer Prev Res (Phila) 4, 18731883.CrossRefGoogle ScholarPubMed
18. Ashbeck, EL, Jacobs, ET, Martinez, ME et al. (2009) Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 18, 11341143.CrossRefGoogle ScholarPubMed
19. Bayerdorffer, E, Mannes, GA, Richter, WO et al. (1993) Decreased high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas. Ann Intern Med 118, 481487.CrossRefGoogle ScholarPubMed
20. Bird, CL, Ingles, SA, Frankl, HD et al. (1996) Serum lipids and adenomas of the left colon and rectum. Cancer Epidemiol Biomarkers Prev 5, 607612.Google ScholarPubMed
21. Bowers, K, Albanes, D, Limburg, P et al. (2006) A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 164, 652664.Google Scholar
22. Chung, YW, Han, DS, Park, YK et al. (2006) Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case–control study in Korea. Dig Liver Dis 38, 668672.CrossRefGoogle Scholar
23. Hu, NC, Chen, JD, Lin, YM et al. (2011) Stepwise relationship between components of metabolic syndrome and risk of colorectal adenoma in a Taiwanese population receiving screening colonoscopy. J Formos Med Assoc 110, 100108.Google Scholar
24. Inoue, M, Noda, M, Kurahashi, N et al. (2009) Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev 18, 240247.CrossRefGoogle ScholarPubMed
25. Iso, H, Ikeda, A, Inoue, M et al. (2009) Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. Int J Cancer 125, 26792686.Google Scholar
26. Kaneko, R, Sato, Y, An, Y et al. (2010) Clinico-epidemiologic study of the metabolic syndrome and lifestyle factors associated with the risk of colon adenoma and adenocarcinoma. Asian Pac J Cancer Prev 11, 975983.Google ScholarPubMed
27. Kim, BC, Shin, A, Hong, CW et al. (2012) Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control 23, 727735.Google Scholar
28. Kono, S, Ikeda, N, Yanai, F et al. (1990) Serum lipids and colorectal adenoma among male self-defence officials in northern Kyushu, Japan. Int J Epidemiol 19, 274278.CrossRefGoogle ScholarPubMed
29. Kono, S, Imanishi, K, Shinchi, K et al. (1993) Serum lipids and left-sided adenomas of the large bowel: an extended study of self-defense officials in Japan. Cancer Causes Control 4, 117121.CrossRefGoogle ScholarPubMed
30. Liu, CS, Hsu, HS, Li, CI et al. (2010) Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol 10, 51.CrossRefGoogle ScholarPubMed
31. Morita, T, Tabata, S, Mineshita, M et al. (2005) The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac J Cancer Prev 6, 485489.Google ScholarPubMed
32. Saydah, SH, Platz, EA, Rifai, N et al. (2003) Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12, 412418.Google Scholar
33. Schoen, RE, Tangen, CM, Kuller, LH et al. (1999) Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91, 11471154.CrossRefGoogle ScholarPubMed
34. Stocks, T, Lukanova, A, Bjorge, T et al. (2010) Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer 117, 23982407.CrossRefGoogle Scholar
35. Sturmer, T, Buring, JE, Lee, IM et al. (2006) Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiol Biomarkers Prev 15, 23912397.CrossRefGoogle ScholarPubMed
36. Tabuchi, M, Kitayama, J & Nagawa, H (2006) Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World J Gastroenterol 12, 12611264.CrossRefGoogle ScholarPubMed
37. Trevisan, M, Liu, J, Muti, P et al. (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 10, 937941.Google Scholar
38. Trichopoulou, A, Tzonou, A, Hsieh, CC et al. (1992) High protein, saturated fat and cholesterol diet, and low levels of serum lipids in colorectal cancer. Int J Cancer 51, 386389.CrossRefGoogle ScholarPubMed
39. Tsilidis, KK, Brancati, FL, Pollak, MN et al. (2010) Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 21, 110.CrossRefGoogle ScholarPubMed
40. Tsushima, M, Nomura, AM, Lee, J et al. (2005) Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Dig Dis Sci 50, 499505.Google Scholar
41. Ulmer, H, Borena, W, Rapp, K et al. (2009) Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer 101, 12021206.Google Scholar
42. Wulaningsih, W, Garmo, H, Holmberg, L et al. (2012) Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study. J Cancer Epidemiol 2012, 792034.CrossRefGoogle ScholarPubMed
43. Yamada, K, Araki, S, Tamura, M et al. (1998) Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ . Int J Epidemiol 27, 794798.CrossRefGoogle ScholarPubMed
44. Ibrahim, YH & Yee, D (2004) Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res 14, 261269.CrossRefGoogle ScholarPubMed
45. Siddiqui, AA (2011) Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci 341, 227231.CrossRefGoogle ScholarPubMed
46. Cowey, S & Hardy, RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169, 15051522.Google Scholar
47. Valko, M, Izakovic, M, Mazur, M et al. (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266, 3756.Google Scholar
48. McKeown-Eyssen, G (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3, 687695.Google Scholar
49. Raju, J & Bird, RP (2003) Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor β and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Cancer Res 63, 65956601.Google ScholarPubMed
50. Niho, N, Mutoh, M, Takahashi, M et al. (2005) Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Proc Natl Acad Sci U S A 102, 29702974.Google Scholar
51. Tornberg, SA, Holm, LE, Carstensen, JM et al. (1986) Risks of cancer of the colon and rectum in relation to serum cholesterol and β-lipoprotein. N Engl J Med 315, 16291633.Google Scholar
52. Kervinen, K, Sodervik, H, Makela, J et al. (1996) Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 110, 17851790.Google Scholar
53. Esteve, E, Ricart, W & Fernandez-Real, JM (2005) Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 24, 1631.CrossRefGoogle ScholarPubMed
54. Hegsted, DM & Kritchevsky, D (1997) Diet and serum lipid concentrations: where are we? Am J Clin Nutr 65, 18931896.Google Scholar
55. Rietman, A, Schwarz, J, Blokker, BA et al. (2014) Increasing protein intake modulates lipid metabolism in healthy young men and women consuming a high-fat hypercaloric diet. J Nutr 144, 11741180.Google Scholar
56. Vargas, AJ & Thompson, PA (2012) Diet and nutrient factors in colorectal cancer risk. Nutr Clin Pract 27, 613623.Google Scholar
57. Vrieling, A & Kampman, E (2010) The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr 92, 471490.CrossRefGoogle ScholarPubMed
Figure 0

Table 1 Studies contributing to the analysis of serum lipids and colorectal cancer

Figure 1

Table 2 Studies contributing to the analysis of serum lipids and colorectal adenoma

Figure 2

Fig. 1 Association between TC and CRN (adenoma and cancer combined): (a) forest plot; (b) funnel plot. In (a), the study-specific RR and 95 % CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond presents the pooled RR risk and its width represents the pooled 95 % CI. In (b), Begg’s funnel plot with pseudo 95 % CI is presented (TC, total cholesterol; CRN, colorectal neoplasm; RR, risk ratio; IV, fixed-effects model; HR, hazard ratio)

Figure 3

Fig. 2 Association between TAG and CRN (adenoma and cancer combined): (a) forest plot; (b) funnel plot. In (a), the study-specific RR and 95 % CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond presents the pooled RR risk and its width represents the pooled 95 % CI. In (b), Begg’s funnel plot with pseudo 95 % CI is presented (CRN, colorectal neoplasm; RR, risk ratio; IV, fixed-effects model; HR, hazard ratio)

Figure 4

Fig. 3 Association between LDL-C and CRN (adenoma and cancer combined): (a) forest plot; (b) funnel plot. In (a), the study-specific RR and 95 % CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond presents the pooled RR risk and its width represents the pooled 95 % CI. In (b), Begg’s funnel plot with pseudo 95 % CI is presented (LDL-C, LDL-cholesterol; CRN, colorectal neoplasm; RR, risk ratio; IV, fixed-effects model; HR, hazard ratio)

Figure 5

Fig. 4 Association between HDL-C and CRN (adenoma and cancer combined): (a) forest plot; (b) funnel plot. In (a), the study-specific RR and 95 % CI are represented by the black square and horizontal line, respectively; the area of the black square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond presents the pooled RR risk and its width represents the pooled 95 % CI. In (b), Begg’s funnel plot with pseudo 95 % CI is presented (HDL-C, HDL- cholesterol; CRN, colorectal neoplasm; RR, risk ratio; IV, fixed-effects model; HR, hazard ratio)

Figure 6

Table 3 Summary risk estimates of the association between serum lipids and colorectal cancer and adenoma risk

Figure 7

Table 4 Results of subgroup analysis of serum lipids and colorectal neoplasm risk

Supplementary material: File

Tian supplementary material

Table S1

Download Tian supplementary material(File)
File 31.2 KB